
Scotland boosts bio-based manufacturing with £75m fund
Scottish Enterprise and Innovate UK will deliver the Launchpad programme, designed to focus on Scotland’s strengths in the sector. The packages,...

Agomab Therapeutics NV raises US$100m in Series C financing
The closed financing round was led by Fidelity Management & Research Company. New investors EQT Life Sciences, Canaan and Dawn Biopharma/KKR, as...

World Health Summit opened in Berlin
At the opening ceremony, German Minister of Health Karl Lauterbach (SPD) said: “The vitalnecessity for the global community is to come together and...

Alfasigma SpA set to take over Galapagos programme
Under the planned agreement, Alfasigma SpA will pay €50m upfront, milestones totaling €120m and mid-single to mid-double digit royalties on European...

Germany boosts protein transition with €38m
Germany is set to follow countries such as the Denmark, the UK and the Netherlands, which this year provided massive funding to become world...

Solar Foods raises €8m in Series B financing
Solar Foods Oy has raised €8m (US$8.8m) from retail investors in Finland. The Series B round was led by Finland’s Springvest Oy, existing...

Oxford Biomedica acquires ABL Europe for €15m
Oxford Biomedica PLC, and Institut Mérieux have entered exclusive negotiations for the acquisition of ABL Europe Inc. This move is set to solidify...